Amrutanjan Healt

55
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
685.00
-10.75 (-1.55%)
BSENSE

Dec 19

BSE+NSE Vol: 16.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Amrutanjan Healt Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Mar'11
No of Months
12
12
12
12
12
12
Profit Before Tax
32.68
24.15
19.38
15.47
16.12
15.60
Adjustment
-1.31
0.33
3.51
3.05
2.73
-1.36
Changes In working Capital
0.81
3.22
1.91
-4.38
-10.13
-4.06
Cash Flow after changes in Working Capital
32.19
27.69
24.80
14.15
8.72
10.18
Cash Flow from Operating Activities
20.70
18.32
17.45
8.62
3.62
5.70
Cash Flow from Investing Activities
4.16
-4.89
16.49
7.73
14.50
-29.43
Cash Flow from Financing Activities
-13.10
-11.93
-13.92
-14.26
-27.31
19.78
Net Cash Inflow / Outflow
11.76
1.49
20.02
2.09
-9.19
-3.95
Opening Cash & Cash Equivalents
30.67
29.17
9.15
7.06
24.43
28.38
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
42.42
30.67
29.17
9.15
15.24
24.43
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Amrutanjan Healt
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
326833398
-7.95
32,68,33,405.00
4111112024.53%
Adjustment
-13061185
-9.87
-1,30,61,176.00
-132332068.19%
Changes In working Capital
8114501
-8.58
81,14,509.00
94574703.73%
Cash Flow after changes in Working Capital
321886714
-26.4
32,18,86,740.00
1219267956.06%
Cash Flow from Operating Activities
206988327
-27.37
20,69,88,354.00
756259972.12%
Cash Flow from Investing Activities
41613603
64.98
4,16,13,539.00
64040532.50%
Cash Flow from Financing Activities
-131041992
-2.66
-13,10,41,990.00
-4926390576.69%
Net Cash Inflow / Outflow
117559938
34.95
11,75,59,904.00
336365960.09%
Opening Cash & Cash Equivalents
306665123
47.17
30,66,65,076.00
650127360.25%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
424225061
82.13
42,42,24,979.00
516528648.33%
Cash Flow - Snapshot (Standalone) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 82.37% vs 38.31% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
50.90
27.91
82.37%